GLAXOSMITHKLINE PHARMACEUTICALS
|
GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Income Statement History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| INCOME : | |||||
| Gross Sales | ₹4,222 Cr | ₹4,123 Cr | ₹3,785 Cr | ₹3,568 Cr | ₹3,594 Cr |
| Sales | ₹4,208 Cr | ₹4,100 Cr | ₹3,773 Cr | ₹3,543 Cr | ₹3,580 Cr |
| Job Work/ Contract Receipts | - | - | - | - | - |
| Processing Charges / Service Income | ₹13 Cr | ₹20 Cr | ₹10 Cr | ₹24 Cr | ₹13 Cr |
| Revenue from property development | - | - | - | - | - |
| Other Operational Income | ₹1.22 Cr | ₹3.43 Cr | ₹1.44 Cr | ₹1.11 Cr | ₹1.24 Cr |
| Less: Excise Duty | - | - | - | - | - |
| Net Sales | ₹3,822 Cr | ₹3,749 Cr | ₹3,454 Cr | ₹3,252 Cr | ₹3,278 Cr |
| EXPENDITURE : | |||||
| Increase/Decrease in Stock | ₹4.46 Cr | ₹46 Cr | ₹-64 Cr | ₹69 Cr | ₹16 Cr |
| Raw Material Consumed | ₹1,347 Cr | ₹1,345 Cr | ₹1,398 Cr | ₹1,216 Cr | ₹1,341 Cr |
| Opening Raw Materials | ₹113 Cr | ₹107 Cr | ₹104 Cr | ₹107 Cr | ₹91 Cr |
| Purchases Raw Materials | ₹416 Cr | ₹506 Cr | ₹548 Cr | ₹425 Cr | ₹627 Cr |
| Closing Raw Materials | ₹93 Cr | ₹113 Cr | ₹107 Cr | ₹104 Cr | ₹107 Cr |
| Other Direct Purchases / Brought in cost | ₹910 Cr | ₹845 Cr | ₹853 Cr | ₹788 Cr | ₹729 Cr |
| Other raw material cost | - | - | - | - | - |
| Power & Fuel Cost | ₹30 Cr | ₹30 Cr | ₹30 Cr | ₹30 Cr | ₹28 Cr |
| Electricity & Power | ₹30 Cr | ₹30 Cr | ₹30 Cr | ₹30 Cr | ₹28 Cr |
| Oil, Fuel & Natural gas | - | - | - | - | - |
| Coals etc | - | - | - | - | - |
| Other power & fuel | - | - | - | - | - |
| Employee Cost | ₹607 Cr | ₹580 Cr | ₹624 Cr | ₹595 Cr | ₹610 Cr |
| Salaries, Wages & Bonus | ₹538 Cr | ₹529 Cr | ₹569 Cr | ₹542 Cr | ₹553 Cr |
| Contributions to EPF & Pension Funds | ₹21 Cr | ₹21 Cr | ₹21 Cr | ₹22 Cr | ₹23 Cr |
| Workmen and Staff Welfare Expenses | ₹19 Cr | ₹16 Cr | ₹16 Cr | ₹21 Cr | ₹19 Cr |
| Other Employees Cost | ₹28 Cr | ₹15 Cr | ₹19 Cr | ₹11 Cr | ₹15 Cr |
| Other Manufacturing Expenses | ₹101 Cr | ₹114 Cr | ₹114 Cr | ₹99 Cr | ₹120 Cr |
| Sub-contracted / Out sourced services | - | - | - | - | - |
| Processing Charges | - | - | - | - | - |
| Repairs and Maintenance | ₹25 Cr | ₹23 Cr | ₹21 Cr | ₹19 Cr | ₹22 Cr |
| Packing Material Consumed | - | - | - | - | - |
| Other Mfg Exp | ₹77 Cr | ₹91 Cr | ₹93 Cr | ₹80 Cr | ₹98 Cr |
| General and Administration Expenses | ₹163 Cr | ₹194 Cr | ₹191 Cr | ₹189 Cr | ₹144 Cr |
| Rent , Rates & Taxes | ₹16 Cr | ₹55 Cr | ₹50 Cr | ₹66 Cr | ₹29 Cr |
| Insurance | ₹11 Cr | ₹11 Cr | ₹7.93 Cr | ₹5.10 Cr | ₹5.35 Cr |
| Printing and stationery | ₹18 Cr | ₹16 Cr | ₹16 Cr | ₹12 Cr | ₹12 Cr |
| Professional and legal fees | ₹30 Cr | ₹24 Cr | ₹23 Cr | ₹23 Cr | ₹36 Cr |
| Traveling and conveyance | ₹76 Cr | ₹66 Cr | ₹73 Cr | ₹76 Cr | ₹55 Cr |
| Other Administration | ₹13 Cr | ₹23 Cr | ₹20 Cr | ₹7.77 Cr | ₹7.16 Cr |
| Selling and Distribution Expenses | ₹203 Cr | ₹190 Cr | ₹184 Cr | ₹181 Cr | ₹200 Cr |
| Advertisement & Sales Promotion | ₹128 Cr | ₹120 Cr | ₹109 Cr | ₹109 Cr | ₹128 Cr |
| Sales Commissions & Incentives | ₹25 Cr | ₹22 Cr | ₹21 Cr | ₹19 Cr | ₹21 Cr |
| Freight and Forwarding | ₹51 Cr | ₹47 Cr | ₹54 Cr | ₹52 Cr | ₹51 Cr |
| Handling and Clearing Charges | - | - | - | - | - |
| Other Selling Expenses | - | - | - | - | - |
| Miscellaneous Expenses | ₹56 Cr | ₹73 Cr | ₹68 Cr | ₹69 Cr | ₹58 Cr |
| Bad debts /advances written off | - | - | - | - | - |
| Provision for doubtful debts | - | - | - | - | - |
| Losson disposal of fixed assets(net) | ₹0.05 Cr | ₹1.51 Cr | - | - | - |
| Losson foreign exchange fluctuations | ₹4.76 Cr | ₹2.27 Cr | - | ₹9.91 Cr | ₹5.14 Cr |
| Losson sale of non-trade current investments | - | - | - | - | - |
| Other Miscellaneous Expenses | ₹51 Cr | ₹69 Cr | ₹68 Cr | ₹59 Cr | ₹53 Cr |
| Less: Expenses Capitalised | - | - | - | - | - |
| Total Expenditure | ₹2,512 Cr | ₹2,572 Cr | ₹2,545 Cr | ₹2,447 Cr | ₹2,516 Cr |
| Operating Profit (Excl OI) | ₹1,309 Cr | ₹1,177 Cr | ₹909 Cr | ₹804 Cr | ₹762 Cr |
| Other Income | ₹145 Cr | ₹146 Cr | ₹123 Cr | ₹101 Cr | ₹76 Cr |
| Interest Received | ₹57 Cr | ₹71 Cr | ₹68 Cr | ₹70 Cr | ₹71 Cr |
| Dividend Received | - | - | - | - | - |
| Profit on sale of Fixed Assets | - | - | ₹0.89 Cr | ₹0.03 Cr | ₹0.32 Cr |
| Profits on sale of Investments | ₹80 Cr | ₹70 Cr | ₹49 Cr | ₹31 Cr | ₹0.59 Cr |
| Provision Written Back | - | - | - | - | ₹0.01 Cr |
| Foreign Exchange Gains | - | - | - | - | - |
| Others | ₹9.00 Cr | ₹4.90 Cr | ₹5.08 Cr | ₹0.04 Cr | ₹3.70 Cr |
| Operating Profit | ₹1,455 Cr | ₹1,323 Cr | ₹1,031 Cr | ₹905 Cr | ₹838 Cr |
| Interest | ₹2.73 Cr | ₹1.31 Cr | ₹1.80 Cr | ₹1.81 Cr | ₹2.00 Cr |
| InterestonDebenture / Bonds | - | - | - | - | - |
| Interest on Term Loan | - | - | - | - | - |
| Intereston Fixed deposits | ₹0.01 Cr | ₹0.13 Cr | ₹0.22 Cr | ₹0.41 Cr | ₹0.26 Cr |
| Bank Charges etc | - | - | - | - | - |
| Other Interest | ₹2.72 Cr | ₹1.18 Cr | ₹1.58 Cr | ₹1.40 Cr | ₹1.74 Cr |
| PBDT | ₹1,452 Cr | ₹1,322 Cr | ₹1,029 Cr | ₹903 Cr | ₹836 Cr |
| Depreciation | ₹66 Cr | ₹67 Cr | ₹70 Cr | ₹66 Cr | ₹68 Cr |
| Profit Before Taxation & Exceptional Items | ₹1,385 Cr | ₹1,255 Cr | ₹960 Cr | ₹837 Cr | ₹767 Cr |
| Exceptional Income / Expenses | ₹21 Cr | ₹4.69 Cr | ₹-144 Cr | ₹-0.97 Cr | ₹12 Cr |
| Profit Before Tax | ₹1,406 Cr | ₹1,260 Cr | ₹816 Cr | ₹836 Cr | ₹779 Cr |
| Provision for Tax | ₹370 Cr | ₹332 Cr | ₹226 Cr | ₹229 Cr | ₹398 Cr |
| Current Income Tax | ₹361 Cr | ₹326 Cr | ₹238 Cr | ₹247 Cr | ₹220 Cr |
| Deferred Tax | ₹9.46 Cr | ₹6.34 Cr | ₹-11 Cr | ₹-18 Cr | ₹-9.40 Cr |
| Other taxes | - | - | - | - | ₹188 Cr |
| Profit After Tax | ₹1,036 Cr | ₹928 Cr | ₹590 Cr | ₹608 Cr | ₹381 Cr |
| Extra items | - | - | - | ₹3.05 Cr | ₹1,314 Cr |
| Minority Interest | - | - | - | - | - |
| Share of Associate | - | - | - | - | - |
| Other Consolidated Items | - | - | - | - | - |
| Consolidated Net Profit | ₹1,036 Cr | ₹928 Cr | ₹590 Cr | ₹611 Cr | ₹1,695 Cr |
| Adjustments to PAT | - | - | - | - | - |
| Profit Balance B/F | ₹1,059 Cr | ₹876 Cr | ₹829 Cr | ₹1,743 Cr | ₹556 Cr |
| Appropriations | ₹2,095 Cr | ₹1,804 Cr | ₹1,419 Cr | ₹2,353 Cr | ₹2,251 Cr |
| General Reserves | - | - | - | - | - |
| Proposed Equity Dividend | - | - | - | - | - |
| Corporate dividend tax | - | - | - | - | - |
| Other Appropriation | ₹712 Cr | ₹542 Cr | ₹542 Cr | ₹1,525 Cr | ₹508 Cr |
| Equity Dividend % | ₹570.00 | ₹540.00 | ₹320.00 | ₹320.00 | ₹900.00 |
| Earnings Per Share | ₹61.15 | ₹54.76 | ₹34.83 | ₹36.05 | ₹100.04 |
| Adjusted EPS | ₹61.15 | ₹54.76 | ₹34.83 | ₹36.05 | ₹100.04 |
Compare Income Statement of peers of GLAXOSMITHKLINE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAXOSMITHKLINE PHARMACEUTICALS | ₹39,885.2 Cr | 3.9% | 2.4% | -27% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹449,803.0 Cr | 2.8% | 1.8% | 13.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,219.0 Cr | -0.2% | -0.1% | 3.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹152,417.0 Cr | 1.4% | -1.5% | 39.9% | Stock Analytics | |
| CIPLA | ₹116,116.0 Cr | 6% | 1.7% | -4.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,874.0 Cr | 4.8% | -0.3% | -0.9% | Stock Analytics | |
GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAXOSMITHKLINE PHARMACEUTICALS | 3.9% |
2.4% |
-27% |
| SENSEX | -0.2% |
2.1% |
-5.6% |
You may also like the below Video Courses